Lung cancer Page
[…] models for studying the effects of KRAS-G12C inhibition on the tumour microenvironment and anti-tumour immunity. KPAR cell lines, developed from tumours in an immunogenic syngeneic transplantation model of KRAS-mutant lung […]
[…] models for studying the effects of KRAS-G12C inhibition on the tumour microenvironment and anti-tumour immunity. KPAR cell lines, developed from tumours in an immunogenic syngeneic transplantation model of KRAS-mutant lung […]
KPAR-G12C Cell Line: Mouse models of mutant KRAS-driven lung cancer with an elevated tumour mutational burden by expressing the human DNA cytosine deaminase, APOBEC3B, to mimic the mutational signature […]
Mouse models of mutant KRAS-driven lung cancer with an elevated tumour mutational burden by expressing the human DNA cytosine deaminase, APOBEC3B
Please note we may take up to three days to respond to your enquiry.
CancerTools.org uses the contact information provided to respond to you about our research tools and service. For more information please review our privacy policy.